Overview
Corporate Profile
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Clovis’ development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from their use. Clovis believes this approach to precision medicine – to deliver the right drMore >>
Stock Chart
Stock Quote
(Common Stock) | |
Exchange | (US Dollar) |
Price | |
Change (%) | |
Intraday High | |
Intraday Low | |
Volume | |
|
Copyright Nasdaq. Minimum 15 minutes delayed.